FitLife Brands

FTLF · NASDAQ

$8.13−$0.10 (−1.22%)TodayMarket closed ·
Prev close $8.23

About FTLF

FitLife Brands, Inc. engages in the provision of nutritional supplements for health conscious consumers. The company is headquartered in Omaha, Nebraska and currently employs 81 full-time employees. The company went IPO on 2007-10-26. The company markets approximately 250 different products primarily online, through domestic and international GNC franchise locations as well as through various retail locations. The company offers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition (together, NDS Products); iSatori, BioGenetic Laboratories, and Energize (together, the iSatori Products); Dr. Tobias, All Natural Advice, and Maritime Naturals (together, the MRC Products) and MusclePharm. Its NDS brand includes premium weight loss, sports nutrition, and general health products. Its PMD brand includes premium sports nutrition products. Its Nutrology brand included sports nutrition and general wellness products with an emphasis on natural, vegan, and organic ingredients. Its SirenLabs brand includes weight loss and sports nutrition products.

Employees
81
Headquarters
Omaha, Nebraska
Listed
Oct 26, 2007
Sector
Consumer Staples
Industry
Personal Care Products

FTLF key statistics

Market cap
76.35M
Price-earnings ratio
13.27
Dividend yield
—
Average volume
13.47K
Volume
6.49K
Open price
$8.30
High today
$8.35
Low today
$8.13
52 Week high
$19.95
52 Week low
$8.05

FitLife Brands (FTLF) at a glance

As of Oct 20, 2026, FitLife Brands (FTLF) shares are priced at $8.13, giving the company a market cap of 76.35M and a price-to-earnings ratio of 13.27.

Today the stock has traded between $8.13 and $8.35. The current price is 0.0% above the day's low and 2.6% below its high.

Volume so far is 6.49K shares, below the average of 13.47K shares a day.

Over the past year FitLife Brands has ranged from $8.05 to $19.95, and now sits 1% of the way up that range.

FitLife Brands met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.20 per share against an estimate of $0.1989.

The average analyst price target is $17.85, 119.6% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $17.85
Low
$17.17
Now
$8.13
High
$18.90

FTLF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 11.6% on average.

  1. Q3 FY24: reported $0.215 per share against an estimate of $0.255
  2. Q4 FY24: reported $0.245 per share against an estimate of $0.2932
  3. Q1 FY25: reported $0.20 per share against an estimate of $0.2499
  4. Q2 FY25: reported $0.18 per share against an estimate of $0.1785
  5. Q3 FY25: reported $0.12 per share against an estimate of $0.2754
  6. Q4 FY25: reported $0.164 per share against an estimate of $0.2193
  7. Q1 FY26: reported $0.17 per share against an estimate of $0.1275
  8. Q2 FY26: reported $0.20 per share against an estimate of $0.1989

FTLF news

  • Press releaseGlobe Newswire

    FitLife Brands Announces Second Quarter 2026 Results

  • Press releaseGlobe Newswire

    FitLife Brands Announces First Quarter 2026 Results

  • Press releaseGlobe Newswire

    FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

  • Press releaseGlobe Newswire

    FitLife Brands Announces Third Quarter 2025 Results

  • Earnings Outlook For FitLife Brands

  • Press releaseGlobe Newswire

    FitLife Brands Announces Second Quarter 2025 Results

  • A Peek at FitLife Brands's Future Earnings

  • Press releaseGlobe Newswire

    FitLife Brands Announces First Quarter 2025 Results

Similar companies

Companies in the same industry as FitLife Brands

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.